Goldman Sachs Lowers XPeng Price Target to $20
- Rating
- Buy
- Unchanged
- Target
- $20
- from $23 (−13%)
- Upside
- +95%
- XPEV at $10.24 today
What the analyst said
Goldman Sachs analyst Tina Hou lowered the price target on XPeng (NYSE: XPEV) to $20 (from $23) while maintaining a Buy rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
XPEV trades at $10.24. The 7 analysts who set a target in the last 3 months range from $10 to $22, with a median of $16. This $20 target is 25% above the median.
Since the note XPEV has moved −21% (from $13). 12-month window: day 95 of 365, closes on August 3, 2027.
Track record
This callOpen: XPEV has not reached $20 yet. This 12-month target is scored on August 3, 2027.
Firm track recordGoldman Sachs: 78% of its 37 targets at least a year old were reached within 12 months (#17 of 26 firms). Accuracy ranking →
Goldman Sachs on XPeng
Goldman Sachs price targets on XPeng
4 calls from November 19, 2025 to October 23, 2026. The target went from $25 to $16 (−36%). The rating moved from Hold to Buy.
- October 23, 2026Target cut from $20 (−20%)Buy$16
- August 3, 2026 This noteTarget cut from $22 (−9%)Buy$20
- February 12, 2026Upgraded to Buy, target cut from $25 (−12%)Buy$22
- November 19, 2025Earliest call shownHold$25
